MISSION ROLL CALL for MISSION ROLL CALL
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL DESMOND | — |
Budget/Appropriations BUD
HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL DESMOND | — |
Health Issues HCR
HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL DESMOND | — |
Medical/Disease Research/Clinical Labs MED
HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL DESMOND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.